View the Latest: Family Planning
Filter
-
-
The U.S. Government and International Family Planning & Reproductive Health Efforts
Fact SheetThis fact sheet examines the U.S. government’s role in family planning and reproductive health (FP/RH) worldwide.
-
KFF Examines Key Considerations for the Implementation of Insurance Coverage for Over-the-Counter Contraceptives
News ReleaseWith federal regulators seeking public input on the potential benefits, costs, and implementation considerations of requiring private health insurance plans to cover over-the-counter preventive products without a prescription, a new KFF post explores the issues relevant to covering over-the-counter contraceptives.
-
Considerations for Covering Over-the-Counter Contraception
Policy WatchIn October 2023, the Departments of the Treasury, Labor, and Health and Human Services issued a request for information to gather public input about the potential benefits, costs, and implementation considerations of requiring private health insurance plans to cover OTC preventive services and supplies without a prescription. This policy watch addresses key considerations for the implementation of insurance coverage for non-prescribed OTC contraceptives based on the lessons learned from KFF’s 2023 study of Insurance Coverage of OTC Oral Contraceptives.
-
The Title X Network Has Largely Returned Under the Biden Administration
News ReleaseA new KFF brief examines the return of grantees and clinic sites to the Title X network under the Biden Administration, which reversed Trump Administration regulations that prohibited Title X sites from providing abortion referrals and having co-located abortion services.
-
Rebuilding the Title X Network Under the Biden Administration
Issue BriefThis issue brief examines what has happened to the Title X network under the Biden Administration regulations, including the number of clinics that have returned to the network, new funding, and how state policies that prohibit pregnancy options counseling that includes abortion and referrals may impact grantees' participation in the Title X program.
-
Who Uses Telecontraception and Why? A Closer Look at Clients of Four Telecontraception Companies
Issue BriefBased on the findings of a nonprobability sample of 6,000 survey respondents from four telecontraception companies, this brief presents a snapshot of telecontraception users and their reasons for using these platforms.
-
Donor Government Funding for Family Planning in 2021
ReportIn 2021, donor government funding for family planning activities totaled US$1.39 billion, essentially flat compared to the 2020 amount (US$1.41 billion). This report provides an analysis of donor government funding to address family planning in low- and middle-income countries in 2021.
-
Interest in Using Over-the-Counter Oral Contraceptive Pills: Findings from the 2022 KFF Women’s Health Survey
Issue BriefThis brief presents data from the 2022 KFF Women’s Health Survey about reproductive age (18-49) females’ preferences for an over-the-counter contraceptive pill (N = 4,088).
-
Contraception in the United States: A Closer Look at Experiences, Preferences, and Coverage
ReportThis report provides a close examination of reproductive age (18-49) females' (including those who identify as women and other genders) experiences with contraception, insurance coverage, contraceptive preferences, and interactions with the health care system based on an analysis of the 2022 KFF Women's Health Survey, a nationally representative survey of females ages 18-64 in the United States.